Verastem VSTM
NASDAQ VSTM
$8.15 +0.17 (+2.19%)
As of: Sep 4, 2026 · 3:20 PM EDT

Verastem (VSTM) Net Equity Issued and Repurchased (2011 - 2025)

Verastem (VSTM) posted quarterly Net Equity Issued and Repurchased of $96.9 million for Q4 2025, up 38.53% quarter-over-quarter from $69.9 million in Q2 2025.

Analysis

Verastem (VSTM) Net Equity Issued and Repurchased (2011 - 2025) Analysis & Trends

Verastem's Net Equity Issued and Repurchased history runs 10 years deep, the most recent figure standing at $96.9 million for Q4 2025.

  • In Q4 2025, Net Equity Issued and Repurchased changed N/A year-over-year to $96.9 million; the TTM figure through Dec 2025 stood at $197.0 million (up 40630.04% YoY), while the FY2025 annual figure was $197.0 million, up 1285.11% from the prior year.
  • Net Equity Issued and Repurchased for Q4 2025 stood at $96.9 million, up from $69.9 million in the prior quarter.
  • The five-year high for Net Equity Issued and Repurchased was $96.9 million in Q4 2025, with the low at -$486000.0 in Q3 2023.
  • The 4-year median for Net Equity Issued and Repurchased is $3.9 million (2021), against an average of $23.1 million.
  • The sharpest annual moves came in 2022 and 2023: Net Equity Issued and Repurchased soared 25434.0% in 2022, then slumped 101.9% in 2023.
  • Verastem's Net Equity Issued and Repurchased stood at $6.5 million in 2021, then surged by 291.45% to $25.5 million in 2022, then sank by 101.9% to -$486000.0 in 2023, then soared by 20034.36% to $96.9 million in 2025.
  • Business Quant data shows VSTM's Net Equity Issued and Repurchased at $96.9 million in Q4 2025, $69.9 million in Q2 2025, and $30.2 million in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn -
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn -
5 Revolution Medicines 43.98 Bn 43.98 Bn - 141.90 Mn
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn -
8 Royalty Pharma 28.42 Bn 27.58 Bn - -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn -
10 Verastem 815.85 Mn 679.49 Mn 36.32 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 96.88 Mn
Jun 30, 2025 69.93 Mn
Mar 31, 2025 30.16 Mn
Sep 30, 2023 -486,000.00
Sep 30, 2022 25.53 Mn
Jun 30, 2022 1.24 Mn
Mar 31, 2022 580,000.00
Dec 31, 2021 6.52 Mn
Sep 30, 2021 100,000.00
Mar 31, 2021 100,000.00
Sep 30, 2020 -10,000.00
Jun 30, 2020 12.13 Mn
Mar 31, 2020 93.94 Mn
Sep 30, 2019 400,000.00
Sep 30, 2018 -301,000.00
Jun 30, 2018 105.16 Mn
Mar 31, 2018 299,000.00
Dec 31, 2015 51,000.00
Sep 30, 2015 250,000.00
Jun 30, 2015 6.20 Mn